Chipscreen Overview

  • Founded

  • 2001

Founded
  • Status

  • Public

  • Employees

  • 1,045

Employees
  • Stock Symbol

  • 688321

Stock Symbol
  • Share Price

  • $3.29

  • (As of Friday Closing)

Chipscreen General Information

Description

Shenzhen Chipscreen Biosciences Co Ltd is engaged in the research and development of small molecule drugs.

Contact Information

Website
www.chipscreen.com
Formerly Known As
Microchip
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
SHG
Primary Office
  • 21-24F, Block B, Zhigu Industrial Park
  • No. 3157, Shahe West Road, Nanshan District
  • Shenzhen, Guangdong
  • China
+86 0755 0000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chipscreen Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.29 $3.25 $2.92 - $4.78 $1.35B 411M 3.98M

Chipscreen Financials Summary

In Thousands,
USD 		TTM 31-Mar-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020
EV 1,686,433 1,293,128 2,212,930 2,294,056
Revenue 77,598 78,690 66,663 39,005
EBITDA 590 9,672 5,437 4,335
Net Income (1,642) 2,596 3,401 4,494
Total Assets 437,281 419,724 297,204 265,281
Total Debt 121,870 117,416 23,764 10,230
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Chipscreen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Chipscreen‘s full profile, request access.

Request a free trial

Chipscreen Patents

  • 109

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 11

    Granted

  • 10

    Pending

  • 000

    Expiring in next 12 mo

Chipscreen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021369898-A1 Biphenyl compound as immunomodulator, preparation method therefor and application thereof Pending 29-Oct-2020
CA-3197685-A1 Biphenyl compound as immunomodulator, preparation method therefor and application thereof Pending 29-Oct-2020
US-20230117545-A1 Pharmaceutical composition comprising protein kinase inhibitor and chemotherapeutic drug and use thereof Pending 24-Mar-2020 000000000
JP-2023520383-A Pharmaceutical composition containing protein kinase inhibitor and chemotherapeutic agent and use thereof Pending 24-Mar-2020
AU-2021244744-A1 Pharmaceutical composition comprising protein kinase inhibitor and chemotherapeutic drug and use thereof Pending 24-Mar-2020 A61K31/47
To view Chipscreen’s complete patent history, request access »

Chipscreen Executive Team (7)

Name Title Board Seat Contact Info
Xianping Lu Ph.D Co-Founder & Chairman & General Manager
Jianxun Li Director and Deputy General Manager, Financial Department
Ou Hai Director, Deputy General Manager, and Secretary of the Board
Zhiqiang Ning Ph.D Co-Founder & Deputy General Manager
Sumei Zhao Deputy General Manager, Brand and Public Affairs
You’re viewing 5 of 7 executive team members. Get the full list »

Chipscreen Board Members (2)

Name Representing Role Since
Xianping Lu Ph.D Chipscreen Co-Founder & Chairman & General Manager 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Chipscreen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial